Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Enrollment complete in Apios's phase I/II trial of bryostatin-1 in HIV infection

June 8, 2015

Cannabis Science and IGXBio to investigate combination of CS-TATI-1 and GenePro in HIV

June 2, 2015

EMA validates MAA for emtricitabine/tenofovir alafenamide fumarate for HIV

May 29, 2015

Johnson & Johnson expands policy to enhance access to darunavir

May 19, 2015

GSK and UNC-Chapel Hill form partnership to seek cure for HIV/AIDS

May 12, 2015

CytoDyn submits full phase III protocol to FDA for PRO-140 in HIV

May 6, 2015

Dosing begins in Nigerian bridging study of Lodonal for HIV/AIDS

May 5, 2015

Dutrebis approved in E.U. for HIV-1 infection

April 23, 2015

Merck & Co. discloses HIV integrase inhibitors

April 14, 2015

Merck & Co. patents HIV integrase inhibitors

April 10, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...